arrow
S

Shingo Nakayamada

University of Occupational and Environmental Health
H指数:49
被引数:9,019

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients

糖化间隙与日本2型糖尿病患者低血糖连续血糖监测指标、糖尿病并发症及生活质量的相关性

2026-09-150
OAAI
Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis

类风湿关节炎相关进行性肺纤维化中生物制剂改善病情抗风湿药的有效性

2026-08-200
PRE
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study

生物制剂/靶向合成改善病情抗风湿药物不能阻止类风湿关节炎患者的骨质流失:一项长期多中心观察性研究

2026-03-080
OA
Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry

沙利鲁单抗在风湿性多肌痛中的有效性与安全性:FIRST登记研究的回顾性研究

2026-01-010
PRE
Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study

运动诱发性肺动脉高压与系统性硬化症中甲襞毛细血管密度的关联:一项单中心回顾性观察性研究

2025-08-290
OA
Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study

糖皮质激素减量速度对增生性狼疮肾炎肾功能结局的影响:一项多中心回顾性研究

2025-05-130
PRE
Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry

FIRST注册研究中对对一线b/tsDMARDs无应答的类风湿关节炎患者有效的二线b/tsDMARDs

2025-03-011
OA
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry

将生物DMARDs与JAK抑制剂序贯疗法用于对JAK抑制剂应答不足的类风湿关节炎患者:来自FIRST注册研究

2025-01-211
OA